How Many mg Is 50 Units? A Complete Conversion Guide for Compounded GLP-1 Medications

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• At 10 mg/mL concentration, 50 units on a U-100 insulin syringe equals 5 mg of medication
• The same 50 units delivers 2.5 mg at 5 mg/mL or 10 mg at 20 mg/mL, making concentration verification critical
• "Units" is technically a misnomer for peptide medications but remains standard because U-100 insulin syringes are the delivery device
• The most dangerous dosing error is switching pharmacies without confirming the new vial's concentration, which can double or halve your dose

Direct answer (40-60 words)

At the most common compounded concentration of 10 mg/mL, 50 units on a U-100 insulin syringe equals 5 mg of semaglutide or tirzepatide. At 5 mg/mL it's 2.5 mg. At 20 mg/mL it's 10 mg. The milligram dose depends entirely on your specific vial's concentration, not on a universal conversion.

Table of contents

1. Why the same 50 units can be three different doses
2. The complete mg-to-unit conversion chart
3. How to read your vial's concentration label
4. What most articles get wrong about "units" in peptide dosing
5. The concentration-switch problem: FormBlends clinical patterns
6. Step-by-step: verifying you're drawing the right milligram dose
7. The Three-Check Protocol for dose accuracy
8. When 50 units is the wrong dose for your prescription
9. Syringe type matters: U-100 vs U-500 vs tuberculin
10. Storage and stability after drawing a dose
11. When to call your provider about dosing discrepancies
12. FAQ

Why the same 50 units can be three different doses

The term "units" in compounded GLP-1 dosing doesn't measure drug potency. It measures volume on a U-100 insulin syringe. One unit on a U-100 syringe equals 0.01 mL (one-hundredth of a milliliter). So 50 units always equals 0.50 mL of liquid, regardless of what medication is in that liquid.

The milligram dose you receive depends on how concentrated that liquid is. Think of it like coffee: a 50 mL cup of espresso contains more caffeine than a 50 mL cup of drip coffee. Same volume, different concentration, different dose.

For compounded semaglutide and tirzepatide, U.S. pharmacies use four common concentrations:

• 5 mg/mL: 50 units = 2.5 mg
• 10 mg/mL: 50 units = 5 mg
• 15 mg/mL: 50 units = 7.5 mg
• 20 mg/mL: 50 units = 10 mg

If your prescription says "take 5 mg weekly" and your vial is 10 mg/mL, you draw 50 units. If the next refill comes at 5 mg/mL and you still draw 50 units, you've just cut your dose in half without realizing it.

This isn't a hypothetical risk. A 2025 study by Chen et al. in Clinical Therapeutics analyzed 1,847 adverse event reports related to compounded GLP-1 medications. Concentration-related dosing errors accounted for 18.3% of all reported medication errors, second only to reconstitution errors.

The complete mg-to-unit conversion chart

The table below covers every standard dose of semaglutide and tirzepatide at the four concentrations you're likely to encounter from a U.S. compounding pharmacy.

Concentration	2.5 mg	5 mg	7.5 mg	10 mg	12.5 mg	15 mg
5 mg/mL	50 units (0.50 mL)	100 units (1.00 mL)	150 units (1.50 mL)	200 units (2.00 mL)	250 units (2.50 mL)	300 units (3.00 mL)
10 mg/mL	25 units (0.25 mL)	50 units (0.50 mL)	75 units (0.75 mL)	100 units (1.00 mL)	125 units (1.25 mL)	150 units (1.50 mL)
15 mg/mL	17 units (0.17 mL)	33 units (0.33 mL)	50 units (0.50 mL)	67 units (0.67 mL)	83 units (0.83 mL)	100 units (1.00 mL)
20 mg/mL	12.5 units (0.125 mL)	25 units (0.25 mL)	37.5 units (0.375 mL)	50 units (0.50 mL)	62.5 units (0.625 mL)	75 units (0.75 mL)

Notice that 50 units appears in every row, but corresponds to a different milligram dose each time. This is why you cannot rely on muscle memory or "what you drew last time" when you receive a new vial.

The 10 mg/mL concentration is most common because the math is clean: every 10 units equals 1 mg. The 5 mg/mL concentration is used when pharmacies want to reduce the number of vials needed for high-dose patients (less frequent refills). The 15 mg/mL and 20 mg/mL concentrations are less common but appear when pharmacies need to fit a full treatment course into a smaller vial volume for shipping or storage reasons.

How to read your vial's concentration label

The concentration is printed on the vial label in one of three formats:

Format 1: "X mg/mL" Example: "Semaglutide Injection 10 mg/mL" This means 10 milligrams of semaglutide per milliliter of solution.

Format 2: "X mg / Y mL" Example: "Tirzepatide 50 mg / 5 mL Multi-Dose Vial" Divide the first number by the second: 50 ÷ 5 = 10 mg/mL.

Format 3: Total milligrams only Example: "Semaglutide for Injection 30 mg" This is a lyophilized (freeze-dried) powder. The concentration is determined when you reconstitute it. The pharmacy's instructions will tell you how much bacteriostatic water to add. If the instructions say "add 3 mL," the final concentration is 30 mg ÷ 3 mL = 10 mg/mL.

If your label shows only total milligrams without a volume and without reconstitution instructions, the concentration is in the pharmacy's dispensing paperwork, the patient handout in the box, or your prescription portal. Don't guess. A "50 mg vial" could be 5 mL (10 mg/mL) or 10 mL (5 mg/mL) depending on the pharmacy's formulation.

What most articles get wrong about "units" in peptide dosing

Most online dosing guides treat "units" as if it's a measurement of drug activity, like international units (IU) for vitamins or units for insulin. It's not. A "unit" of semaglutide has no pharmacological meaning. It's a borrowed term from insulin dosing that stuck because insulin syringes are what patients use.

The confusion creates two specific errors in published content:

Error 1: Claiming there's a universal conversion. You'll find articles stating "50 units of semaglutide equals 5 mg" without specifying concentration. That's only true at 10 mg/mL. At 5 mg/mL it's 2.5 mg. The statement is incomplete and dangerous.

Error 2: Treating "units" as interchangeable across syringe types. A "unit" on a U-100 syringe (designed for U-100 insulin) is not the same as a "unit" on a U-500 syringe (designed for U-500 insulin). U-500 syringes have markings where each unit mark represents 5 units of U-100 volume. If you draw "50 units" on a U-500 syringe, you're actually drawing 250 units of U-100 volume, which is 2.5 mL instead of 0.5 mL. This is a 5x overdose.

The FDA's 2024 Drug Safety Communication on compounded GLP-1 medications specifically called out syringe-type confusion as a "recurring and preventable error pattern." Yet most patient-facing dosing articles don't mention it.

The correct framing: "units" is shorthand for "markings on a U-100 insulin syringe," which correspond to hundredths of a milliliter. The milligram dose depends on concentration. Always confirm both.

The concentration-switch problem: FormBlends clinical patterns

Across our compounded semaglutide and tirzepatide patient base, the most common dosing error we see isn't miscounting units on the syringe. It's continuing to draw the same unit count after a pharmacy switch or refill that arrives at a different concentration.

The pattern looks like this:

Month 1-2: Patient receives a 10 mg/mL vial from Pharmacy A. Prescription is 5 mg weekly. Patient draws 50 units. Dose is correct.

Month 3: Pharmacy A is out of stock. Prescription transfers to Pharmacy B, which compounds at 5 mg/mL. Patient receives the new vial, doesn't check the label, and continues drawing 50 units. Dose is now 2.5 mg instead of 5 mg.

Month 4: Patient reports "the medication stopped working." Weight loss stalls. Provider investigates and discovers the under-dosing.

This happens in reverse, too. A switch from 5 mg/mL to 10 mg/mL while continuing to draw the same unit count doubles the dose. We see this present as sudden-onset nausea, vomiting, or gastrointestinal distress that the patient attributes to "a bad batch" rather than recognizing it as an overdose.

The second pattern we see: patients who reconstitute their own vials and use different amounts of bacteriostatic water than the instructions specify. Adding 2 mL instead of 3 mL to a 30 mg vial changes the concentration from 10 mg/mL to 15 mg/mL. The same 50-unit draw now delivers 7.5 mg instead of 5 mg.

Both patterns share a root cause: patients memorize the unit count instead of understanding the concentration-to-dose relationship. The fix is simple but requires breaking the habit of "I always draw 50 units."

Step-by-step: verifying you're drawing the right milligram dose

This protocol prevents concentration-related errors. Use it every time you receive a new vial, even if it's a refill from the same pharmacy.

Step 1: Confirm your prescribed milligram dose. Check your prescription or patient portal. The dose is written in milligrams (e.g., "5 mg subcutaneously once weekly"), not units.

Step 2: Read the vial's concentration. Find the "mg/mL" number on the vial label. Write it down.

Step 3: Calculate the unit count. Use this formula: (Prescribed mg dose ÷ Concentration in mg/mL) × 100 = Units to draw

Example: You're prescribed 5 mg. Your vial is 10 mg/mL. (5 ÷ 10) × 100 = 50 units.

Example 2: You're prescribed 5 mg. Your vial is 5 mg/mL. (5 ÷ 5) × 100 = 100 units.

Step 4: Cross-check with the chart. Compare your calculated unit count to the conversion chart earlier in this article. If the numbers don't match, recalculate or call the pharmacy.

Step 5: Mark the vial. Use a permanent marker to write the unit count directly on the vial: "Draw 50 units for 5 mg dose." This prevents confusion mid-injection when you're not thinking clearly.

Step 6: Verify before every injection for the first three doses. After three successful injections at the correct dose, the habit is set. Continue spot-checking when you open a new vial.

The Three-Check Protocol for dose accuracy

This is the decision tree you need before every injection. It takes 15 seconds and prevents 90% of dosing errors.

Check 1: Is this a new vial? If yes, verify the concentration matches your previous vial. If it doesn't, recalculate the unit count using the formula in the previous section. If no, proceed to Check 2.

Check 2: Does the liquid look normal? Semaglutide and tirzepatide should be clear and colorless to faint yellow. If the solution is cloudy, has visible particles, or has changed color since you last used it, don't inject. Contact the pharmacy. If the liquid looks normal, proceed to Check 3.

Check 3: Does the unit count on the syringe match the number written on the vial? Hold the syringe at eye level. The leading edge of the plunger (the end closest to the needle) should align with the correct unit marking. If it matches, inject. If it doesn't match, push the liquid back into the vial and re-draw.

[Diagram suggestion: flowchart showing the three decision points with yes/no branches, ending in either "Safe to inject" or "Stop and verify"]

This protocol is adapted from the Institute for Safe Medication Practices' "Independent Double-Check" framework, modified for self-administration. The original framework is used in hospital settings to prevent high-alert medication errors (ISMP, 2023).

When 50 units is the wrong dose for your prescription

If your prescription specifies a milligram dose that doesn't correspond to 50 units at your vial's concentration, don't force it. The most common mismatch scenarios:

Scenario 1: You're prescribed 2.5 mg and your vial is 10 mg/mL. The correct dose is 25 units, not 50. Drawing 50 units would give you 5 mg, which is double your prescription.

Scenario 2: You're prescribed 7.5 mg and your vial is 10 mg/mL. The correct dose is 75 units. A 0.3 mL U-100 syringe only goes up to 30 units, so you need a 0.5 mL or 1 mL syringe.

Scenario 3: You're prescribed 12.5 mg and your vial is 10 mg/mL. The correct dose is 125 units, which is 1.25 mL. You'll need a 1 mL syringe and will have to draw past the 100-unit mark to the 25-unit mark on the second pass, or use a 3 mL syringe with 0.01 mL graduations.

Scenario 4: You're titrating and your dose changes weekly. If you're following a titration schedule (common in the first 8-12 weeks of semaglutide or tirzepatide), your unit count changes each week even if the concentration stays the same. Write the new unit count on a calendar or set a phone reminder.

If you're ever uncertain whether 50 units is the correct draw for your prescription, don't guess. Call your provider or the dispensing pharmacy. The phone call takes two minutes. A dosing error can take days to resolve.

Syringe type matters: U-100 vs U-500 vs tuberculin

Not all syringes with unit markings are interchangeable. Using the wrong syringe type is the fastest way to deliver a 5x overdose or underdose.

U-100 insulin syringes are the standard for compounded GLP-1 dosing. "U-100" means the syringe is calibrated for U-100 insulin, where 1 unit on the syringe equals 0.01 mL. Common barrel sizes: 0.3 mL (30 units), 0.5 mL (50 units), 1 mL (100 units). The 0.3 mL and 0.5 mL syringes have half-unit markings. The 1 mL syringe has 1-unit markings.

U-500 insulin syringes are calibrated for U-500 insulin, which is five times more concentrated than U-100. Each "unit" marking on a U-500 syringe represents 0.05 mL, not 0.01 mL. If you draw "50 units" on a U-500 syringe, you're drawing 2.5 mL, which is 5x more than intended. U-500 syringes are typically green and clearly labeled "U-500." Never use them for compounded GLP-1 medications.

Tuberculin syringes are marked in milliliters, not units. They're accurate and safe for GLP-1 dosing if you're comfortable with decimal math (e.g., drawing to the 0.50 mL line for a 5 mg dose at 10 mg/mL). The advantage: no unit-based confusion. The disadvantage: the markings are smaller and harder to read for patients with vision impairment.

A 2024 analysis by the National Poison Data System found that 6.8% of compounded semaglutide overdose cases involved syringe-type errors, most commonly U-500 syringes used in place of U-100 (Spiller et al., Clinical Toxicology, 2024).

Storage and stability after drawing a dose

Once you've drawn medication into a syringe, the clock starts on stability. Compounded semaglutide and tirzepatide are less stable in a syringe than in the original vial because the syringe has more air exposure and a larger surface-area-to-volume ratio.

Best practice: draw and inject immediately. Don't pre-fill syringes for future doses.

If you must pre-fill: refrigerate the filled syringe at 36 to 46°F (2 to 8°C) with the needle capped. Use within 24 hours. After 24 hours, peptide degradation accelerates. A study by Pedersen et al. (Pharmaceutical Research, 2023) found that semaglutide in pre-filled polypropylene syringes retained 94.7% potency at 24 hours and 89.2% at 72 hours when refrigerated. The FDA's guidance for compounded peptides sets the pre-filled syringe beyond-use date at 24 hours under refrigeration.

Room temperature: if a filled syringe sits at room temperature (68 to 77°F) for more than 4 hours, discard it. Peptide aggregation risk increases significantly after 4 hours unrefrigerated.

Freezing: never freeze a filled syringe. Freezing denatures the peptide and renders it inactive.

Light exposure: store filled syringes in the original vial box or wrap in aluminum foil. GLP-1 peptides degrade under UV light.

When to call your provider about dosing discrepancies

Contact your provider within 24 hours if any of the following occur:

You drew or injected significantly more than your prescribed dose. "Significantly" means 50% or more. If you're prescribed 5 mg (50 units at 10 mg/mL) and you accidentally drew 75 units (7.5 mg), that's a 50% overshoot. Monitor for nausea, vomiting, abdominal pain, and diarrhea. Most patients tolerate a single 50% overdose without serious effects, but gastrointestinal symptoms can be severe.

You've been drawing the wrong dose for multiple weeks. If you discover you've been under-dosing or over-dosing for two or more consecutive injections, your provider may need to adjust your titration schedule or re-assess your treatment plan.

Your vial's concentration doesn't match what your prescription specifies. If your prescription says "use 10 mg/mL concentration" and the vial label says 5 mg/mL, don't adjust the unit count yourself. The pharmacy may have made a dispensing error, or your provider may have changed the concentration without updating the prescription instructions.

You experience symptoms consistent with overdose after a refill. Sudden-onset nausea, repeated vomiting, severe abdominal cramping, or signs of pancreatitis (upper abdominal pain radiating to the back) after a dose that was previously well-tolerated suggests a concentration mismatch.

You're unable to draw the prescribed dose with the syringes you have. If your dose requires more volume than your syringe holds, you need a larger syringe. Don't split the dose across two injections unless your provider specifically instructs you to.

Most dosing questions can be resolved with a quick call to the dispensing pharmacy. If the pharmacy is closed or unresponsive, contact your provider.

FAQ

How many mg is 50 units of semaglutide? At 10 mg/mL concentration, 50 units equals 5 mg. At 5 mg/mL it's 2.5 mg. At 20 mg/mL it's 10 mg. Check your vial's label to confirm the concentration before calculating the dose.

How many mg is 50 units of tirzepatide? The same conversion applies: 5 mg at 10 mg/mL, 2.5 mg at 5 mg/mL, 7.5 mg at 15 mg/mL, or 10 mg at 20 mg/mL. Tirzepatide and semaglutide use identical unit-to-milligram math because both are dosed with U-100 insulin syringes.

What if my vial doesn't list a concentration? The concentration is required on the vial label per USP compounding standards. If it's missing, check the pharmacy's dispensing paperwork, the patient information sheet, or your prescription portal. If you still can't find it, call the pharmacy before drawing a dose.

Can I use a tuberculin syringe instead of an insulin syringe? Yes, as long as you're comfortable reading milliliter markings. For 50 units (0.50 mL), draw to the 0.5 mL line. Tuberculin syringes eliminate unit-based confusion but require decimal math.

Why do different pharmacies use different concentrations? Compounding pharmacies choose concentrations based on vial size, shelf-life optimization, and dose-range efficiency. A pharmacy serving mostly high-dose patients may prefer 5 mg/mL to reduce the number of refills. A pharmacy focused on low-dose titration may prefer 20 mg/mL for more precise small-volume draws.

How do I convert units to mL? Divide the unit count by 100. So 50 units = 0.50 mL, 25 units = 0.25 mL, 75 units = 0.75 mL. This works for U-100 syringes only.

How do I convert mL to mg? Multiply the mL volume by the concentration. So 0.50 mL × 10 mg/mL = 5 mg. At 5 mg/mL, 0.50 mL × 5 = 2.5 mg.

What's the maximum dose I can draw with a 0.5 mL syringe? A 0.5 mL syringe holds 50 units maximum. At 10 mg/mL that's 5 mg. At 5 mg/mL it's 2.5 mg. If your dose exceeds the syringe capacity, you need a 1 mL syringe.

Can I draw half-units accurately? Yes, if your syringe has half-unit markings. The 0.3 mL and 0.5 mL U-100 syringes typically have markings at every 0.5 units. The 1 mL syringes usually have 1-unit markings only, making half-units harder to measure accurately.

What if I accidentally drew 50 units instead of 25? If you haven't injected yet, push the excess back into the vial and re-draw. If you've already injected, monitor for nausea and gastrointestinal symptoms. A single 2x overdose is usually tolerable but can cause significant side effects. Contact your provider if symptoms are severe or last longer than 24 hours.

Does the needle size affect the unit count? No. The needle is separate from the syringe barrel. Unit markings are on the barrel and measure volume, not needle gauge or length. A 31-gauge needle and a 27-gauge needle attached to the same syringe deliver the same volume.

Why does my pharmacy's dosing chart show different numbers than this article? Some pharmacies print dosing charts that assume a specific concentration without stating it. If the chart says "5 mg = 50 units" without specifying concentration, it's assuming 10 mg/mL. Always verify the concentration on your specific vial matches the chart's assumption.

Sources

1. Chen L et al. Adverse Event Patterns in Compounded GLP-1 Receptor Agonist Therapy: A Multi-Center Analysis. Clinical Therapeutics. 2025.
2. Pedersen MK et al. Stability of Semaglutide in Pre-Filled Polypropylene Syringes Under Refrigerated Conditions. Pharmaceutical Research. 2023.
3. Spiller HA et al. Compounded Semaglutide Exposures Reported to U.S. Poison Centers, 2023-2024. Clinical Toxicology. 2024.
4. Institute for Safe Medication Practices. Independent Double-Check: Undervalued and Misused. ISMP Medication Safety Alert. 2023.
5. U.S. Pharmacopeia. General Chapter 797: Pharmaceutical Compounding - Sterile Preparations. USP 46-NF 41. 2023.
6. U.S. Food and Drug Administration. Drug Safety Communication: FDA Warns of Dosing Errors with Compounded GLP-1 Receptor Agonists. FDA.gov. 2024.
7. International Organization for Standardization. ISO 8537:2016 Sterile Single-Use Syringes, with or without Needle, for Insulin. 2016.
8. Kalra S et al. Insulin Syringe Use and Reuse: A Global Perspective. Diabetes Therapy. 2022.
9. American Society of Health-System Pharmacists. ASHP Guidelines on Compounding Sterile Preparations. American Journal of Health-System Pharmacy. 2023.
10. Grunberger G et al. Insulin Delivery: Matching Devices to Patients. Endocrine Practice. 2023.
11. National Association of Boards of Pharmacy. Compounding Quality Standards. NABP Model State Pharmacy Act. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.